These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 2551600)
1. Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci. Chandrasekar PH; Sluchak JA Chemotherapy; 1989; 35(5):333-7. PubMed ID: 2551600 [TBL] [Abstract][Full Text] [Related]
2. Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies. Foster JK; Lentino JR; Strodtman R; DiVincenzo C Antimicrob Agents Chemother; 1986 Dec; 30(6):823-7. PubMed ID: 3643771 [TBL] [Abstract][Full Text] [Related]
3. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus. Moorhouse EC; Mulvihill TE; Jones L; Mooney D; Falkiner FR; Keane CT J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632 [TBL] [Abstract][Full Text] [Related]
4. New trends in the chemotherapy of staphylococcal infections. Russo G; Tempera G; Stefani S; Nicoletti G Chemioterapia; 1986 Apr; 5(2):116-9. PubMed ID: 3635440 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates. Kotlus BS; Wymbs RA; Vellozzi EM; Udell IJ Am J Ophthalmol; 2006 Nov; 142(5):726-9. PubMed ID: 17056356 [TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin resistance in methicillin- and gentamicin-resistant Staphylococcus aureus. Maple P; Hamilton-Miller J; Brumfitt W Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):622-4. PubMed ID: 2506023 [TBL] [Abstract][Full Text] [Related]
7. Staphylococcus aureus resistance to antibiotics and spread of phage types. Kareiviene V; Pavilonis A; Sinkute G; Liegiūte S; Gailiene G Medicina (Kaunas); 2006; 42(4):332-9. PubMed ID: 16687905 [TBL] [Abstract][Full Text] [Related]
8. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains. Watanakunakorn C; Tisone JC Antimicrob Agents Chemother; 1982 Nov; 22(5):903-5. PubMed ID: 6924825 [TBL] [Abstract][Full Text] [Related]
9. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Tsuji BT; Rybak MJ Antimicrob Agents Chemother; 2005 Jul; 49(7):2735-45. PubMed ID: 15980344 [TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro susceptibility of besifloxacin and seven comparators against ciprofloxacin- and methicillin-susceptible/nonsusceptible staphylococci. Miller D; Chang JS; Flynn HW; Alfonso EC J Ocul Pharmacol Ther; 2013 Apr; 29(3):339-44. PubMed ID: 23289847 [TBL] [Abstract][Full Text] [Related]
11. In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus. Grohs P; Kitzis MD; Gutmann L Antimicrob Agents Chemother; 2003 Jan; 47(1):418-20. PubMed ID: 12499229 [TBL] [Abstract][Full Text] [Related]
12. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents]. Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259 [TBL] [Abstract][Full Text] [Related]
13. Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci. Lowy FD; Chang DS; Lash PR Antimicrob Agents Chemother; 1983 Jun; 23(6):932-4. PubMed ID: 6555016 [TBL] [Abstract][Full Text] [Related]
14. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species. DeRyke CA; Sutherland C; Zhang B; Nicolau DP; Kuti JL Antimicrob Agents Chemother; 2006 Nov; 50(11):3529-34. PubMed ID: 17065618 [TBL] [Abstract][Full Text] [Related]
15. Gentamicin- and methicillin-resistant Staphylococcus aureus: in vitro susceptibility to antimicrobial drugs. Traub WH; Spohr M; Bauer D Chemotherapy; 1987; 33(5):361-75. PubMed ID: 3665635 [TBL] [Abstract][Full Text] [Related]
16. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci]. Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378 [TBL] [Abstract][Full Text] [Related]
17. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents. Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943 [TBL] [Abstract][Full Text] [Related]
18. Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review. Chang VS; Dhaliwal DK; Raju L; Kowalski RP Cornea; 2015 Jun; 34(6):698-703. PubMed ID: 25811722 [TBL] [Abstract][Full Text] [Related]
19. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci]. Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M; Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529 [TBL] [Abstract][Full Text] [Related]
20. Activity of daptomycin against enterococci and coagulase-negative staphylococci (CNS): relationship between CNS susceptibility and slime production. Marone P; Perversi L; Navarra A; Monzillo V; Sartirana E J Chemother; 1993 Jun; 5(3):151-4. PubMed ID: 8396625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]